erucylphosphohomocholine ErPC3

induces apoptosis in highly apoptosis resistant malignant glioma cell lines and enhance radiation-induced cell death and eradication of clonogenic tumor cells in vitro

Also Known As:

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Alten, Julia: 1 article (07/2010)
2.	Gavish, Moshe: 1 article (07/2010)
3.	Kugler, Wilfried: 1 article (07/2010)
4.	Lakomek, Max: 1 article (07/2010)
5.	Linnemannstöns, Karen: 1 article (07/2010)
6.	Shandalov, Yulia: 1 article (07/2010)
7.	Veenman, Leo: 1 article (07/2010)
8.	Zeno, Sivan: 1 article (07/2010)
9.	Bäsecke, J: 1 article (04/2010)
10.	Cappellini, A: 1 article (04/2010)

Related Diseases

1.	Glioma (Gliomas) 07/01/2010 - "Erucylphosphohomocholine (ErPC3, Erufosine) was reported previously to induce apoptosis in otherwise highly apoptosis-resistant malignant glioma cell lines while sparing their non-tumorigenic counterparts. " 08/01/2006 - "The membrane-targeted apoptosis modulators erucylphosphocholine (ErPC) and erucylphosphohomocholine (ErPC3) induce apoptosis in highly apoptosis resistant malignant glioma cell lines and enhance radiation-induced cell death and eradication of clonogenic tumor cells in vitro. "
2.	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/01/2010 - "We investigated the therapeutic potential of erucylphosphohomocholine (ErPC3), the first intravenously applicable APC, in human acute myelogenous leukemia (AML) cells. "
3.	Neoplasms (Cancer) 08/01/2006 - "The membrane-targeted apoptosis modulators erucylphosphocholine (ErPC) and erucylphosphohomocholine (ErPC3) induce apoptosis in highly apoptosis resistant malignant glioma cell lines and enhance radiation-induced cell death and eradication of clonogenic tumor cells in vitro. "

Related Drugs and Biologics

1.	erucylphospho- N,N,N- trimethylpropylammonium
2.	erucylphosphocholine